Xiaosuo Wang | Technological Networks | Best Researcher Award

Published on by Network Science

Dr. Xiaosuo Wang | Technological Networks | Best Researcher Award

The University of Sydney | Australia

Dr. Xiaosuo Wang is a distinguished researcher specializing in mass spectrometry, metabolomics, lipidomics, and proteomics, with deep expertise in vascular biology and heart failure. She earned her PhD in Medicine from the University of Sydney in 2009, focusing on novel ELISA methods to detect oxidised apolipoproteins in cardiovascular disease, following a master’s degree in Physiology and Pharmacology from the University of New South Wales and a bachelor’s in Biomedical Engineering from the Fourth Military Medical University, China. Currently a Senior Research Fellow and Senior Lecturer at the University of Sydney’s Charles Perkins Centre, she leads pioneering projects in biomarker discovery, metabolic assays, and multi-omics platform development for applications in liver disease, heart failure, and population health. Her work integrates advanced mass spectrometry, lipidomics, and metabolomics workflows with translational innovations such as point-of-care assays and biosensor development. Previously, as a Metabolomics Research Scientist at the Victor Chang Cardiac Research Institute and Manager of the Bosch Mass Spectrometry Facility, she developed over 60 advanced LC-MS assays and supported a wide range of biological and clinical research. Dr. Wang’s prolific contributions include more than 40 peer-reviewed publications, numerous conference presentations, and significant advancements in analytical methodologies for precision medicine.

Profiles: Scopus | Orcid ID

Featured Publications

"Rapid On-Demand Point-of-Care Monitoring of Clozapine and Its Metabolite Norclozapine Using Miniature Mass Spectrometry. Pharmaceuticals, Xiaosuo Wang; Wei Yi Lew; Yang Yang; Nan Zhang; Jiexun Bu; Zhentao Li; Michael Fitzpatrick; Paul Bonnitcha; David Sullivan; Wenpeng Zhang et al., 2025"

"The Heart Has Intrinsic Ketogenic Capacity that Mediates NAD + Therapy in HFpEF, Circulation Research, Yen Chin Koay; Bailey McIntosh; Yann Huey Ng; Yang Cao; Xiao Suo Wang; Yanchuang Han; Saki Tomita; Angela Yu Bai; Benjamin Hunter; Ashish Misra et al., 2025"

"Cardiac Substrate Utilization and Relationship to Invasive Exercise Hemodynamic Parameters in HFpEF, JACC. Basic to translational science, O'Sullivan JF; Li M; Koay YC; Wang XS; Guglielmi G; Marques FZ; Nanayakkara S; Mariani J; Slaughter E; Kaye DM, 2024"

"The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease, Pathology, Qadri S; Wang X; Tran C; Fitzpatrick M; Bonnitcha P; Sullivan D; Yki-Järvinen H; O'Sullivan JF, 2023"

"Destabilization of Atherosclerotic Plaque by Bilirubin Deficiency, Circulation Research, Weiyu Chen; Sergey Tumanov; Christopher P. Stanley; Stephanie M.Y. Kong; James Nadel; Niv Vigder; Darren L. Newington; Xiao Suo Wang; Louise L. Dunn; Roland Stocker, 2025"

Rishi Pandey | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Rishi Pandey | Biological Networks | Best Researcher Award

Western Sydney University | Australia

Author Profile

Scopus

Google Scholar

EARLY ACADEMIC PURSUITS

Rishi Pandey began his journey in the field of science with a deep-rooted passion for biochemistry and analytical chemistry. His foundational academic experiences were marked by a strong inclination toward research and laboratory-based innovations. He cultivated his scientific rigor early, focusing on the integration of chemical principles with biological applications, which laid the groundwork for his later success in biosensor development and molecular diagnostics.

PROFESSIONAL ENDEAVORS

With over a decade of impactful professional experience, Rishi Pandey has held key roles across academia, government-funded research institutions, and biotech start-ups. Currently serving as the Research Manager at the School of Medicine, Western Sydney University, he leads the Mass Spectrometry and Next-Gen Sequencing research platforms. He has also held pivotal roles at Eurofins NZ, Manuka Health Ltd., and Eve Health Labs, where he managed high-value analytical projects, developed cutting-edge testing methods, and led cross-functional teams. His career reflects a strategic balance between scientific depth and operational leadership.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOLOGICAL NETWORK

Rishi Pandey's research interests span analytical chemistry, proteomics, biosensor development, molecular diagnostics, and the application of machine learning for scientific innovation. He is notably recognized for developing an electrochemical biosensor device for point-of-contact drug testing-an innovation that earned him the 2021 KiwiNet Emerging Innovator Award. His leadership in engineering protein-based antiviral candidates and establishing platforms for forensic identification and gut health metabolomics have led to several successful translational research outcomes. He also contributed to the establishment of analytical laboratories and the integration of LEAN and Agile methodologies for efficient scientific workflows.

IMPACT AND INFLUENCE

Rishi Pandey has significantly influenced the scientific and industrial communities by bridging the gap between academic research and commercial science. His leadership has accelerated the development of cost-effective diagnostic and testing solutions, saving organizations hundreds of thousands of dollars. His training programs for postgraduate students and researchers in advanced analytical techniques have elevated the skill sets of future scientists. Moreover, his collaborative partnerships with research institutes in Australia, New Zealand, and the U.S. have facilitated global innovation in biosciences.

ACADEMIC CITES

While specific citation metrics are not disclosed here, Rishi Pandey’s body of work in proteomics, analytical method development, and biosensors contributes to high-impact fields such as forensic science, public health diagnostics, and functional food analytics. His contributions have been instrumental in fostering impactful publications and enabling the development of competitive research proposals within academic and industrial settings.

LEGACY AND FUTURE CONTRIBUTIONS

Rishi Pandey’s legacy is one of translational excellence, scientific curiosity, and strategic leadership. His continued efforts to fuse biochemical research with AI-driven data mining and diagnostics position him as a thought leader in the emerging landscape of precision medicine and bioanalytical technology. Looking forward, his contributions are expected to expand the accessibility of rapid diagnostics, foster global research collaborations, and inspire a new generation of biochemists focused on science commercialization for societal benefit.

OTHER IMPORTANT HIGHLIGHTS

  • Recognized by KiwiNet as an Emerging Innovator for proteomics and biosensor innovations.

  • Spearheaded commercial laboratory growth at Eve Health Labs to exceed $350,000 in annual revenue.

  • Developed and validated critical testing methodologies for high-value nutraceuticals and food safety at Eurofins NZ and Manuka Health Ltd.

  • Expertise spans across analytical instruments such as Thermo Orbitrap, SCIEX, Waters LCMS/MS, and Bruker Q-TOF, contributing to robust quality and analytical assurance.

  • Played a key role in industry-academia interface, fostering cross-border collaborations and industry-aligned research deliverables.

NOTABLE PUBLICATIONS

"Electrochemical Aptamer-Based Biosensors for Cocaine Detection in Human Saliva: Exploring Matrix Interference" 

  • Author: Y Liu, R Pandey, MJ McCarthy, O Raymond
  • Journal: Analytical Chemistry
  • Year: 2025

"Nanoparticle based antigen detection of norovirus in human faecal samples: A proof-of-concept study" 

  • Author: R Pandey, P Gyawali, MAT Blaskovich, KC Sanjaya
  • Journal: Nanoparticle based antigen detection of norovirus in human faecal samples: A proof-of-concept study
  • Year: 2025

"UHPLC and Computational Studies of Chemical Constituents Derived from Myrica esculenta against NADPH Oxidase 2 (NOX2) Protein" 

  • Author: AR Pandey, WA Ansari, P Maurya, H Aslam, RR Pandey, DP Mishra
  • Journal: ChemistrySelect
  • Year: 2025

"Single-Use Electrochemical Aptamer-Based Sensors for Calibration-Free Measurements in Human Saliva via Dual-Frequency Approaches: Prospects and Challenges" 

  • Author: Y Liu, R Pandey, MJ McCarthy, O Raymond
  • Journal: Analytical Chemistry
  • Year: 2025

"Hydrochar from agrowastes: a low-cost adsorbent for environmental application" 

  • Author: RR Pandey, AR Pandey, AK Tripathi, J Kumar
  • Journal: Role of Green Chemistry
  • Year: 2024

Dimitrios G. Tsoukas | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Dimitrios G. Tsoukas | Biological Networks | Best Researcher Award

Mitera Hospital Athens | Greece

Author Profile

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Dr. Dimitrios G. Tsoukas began his academic journey with exceptional distinction, graduating with a Bachelor in Medicine from the National and Kapodistrian University of Athens Faculty of Medicine. His early academic excellence set the foundation for a career rooted in clinical precision and innovative thinking. His education emphasized not only traditional orthopaedic surgery but also introduced him to minimally invasive techniques, which would later define his clinical signature.

PROFESSIONAL ENDEAVORS

Dr. Tsoukas's professional career spans over two decades of dynamic clinical and academic leadership. Currently, he serves as the Director of the E’ Orthopaedic Clinic for Advanced Arthroscopic Sports and Regenerative Surgery at MITERA Hospital (HH Group). He is also an Adjunct Professor at the University of Nebraska-Lincoln (USA) and has held numerous leadership positions at top hospitals across Greece and Cyprus. His pioneering efforts led to the founding of MIOSMED Center, an internationally recognized teaching hub endorsed by ISAKOS, ESSKA, and ICRS, and the Elite Regenerative Clinic Athens, a Lipogems SpA Center of Excellence. His clinical footprint spans not only orthopaedics but also women’s health, athletic injuries, and sports medicine innovation.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOLOGICAL NETWORKS

Dr. Tsoukas is a distinguished authority in arthroscopic, minimally invasive, and regenerative orthopaedic surgery, with special emphasis on adipose-derived stem cell applications for arthritis and joint degeneration. His contributions include advanced biological techniques in cartilage regeneration, joint preservation, and tendon repair. He has played a leading role in global education by serving as a certified instructor for ESSKA, contributing to simulation-based medical training, and mentoring young surgeons. His research interests include low-cost arthroscopy simulators, stem cell therapies, sports injury prevention in children, and medical device innovation.

IMPACT AND INFLUENCE

Dr. Tsoukas is recognized as a Key Opinion Leader (KOL) in orthopaedics and regenerative medicine, actively shaping clinical best practices and treatment protocols. His influence is reflected through editorial board memberships, reviewer roles for high-impact journals like the British Journal of Sports Medicine and the Orthopaedic Journal of Sports Medicine, and his participation in international regulatory and scientific committees. His appointment as a TEDx speaker in Kigali, Rwanda (2023) further underscores his role in global medical outreach and inspiration.

ACADEMIC CITES

As a scientific collaborator, Dr. Tsoukas has contributed to various institutions including the Athens University Medical School, Medical Physics Laboratory Simulation Center, and the European University of Cyprus. He has been involved in academic teaching, research, and publication, significantly advancing clinical education in Europe and the United States. He also served as Editor-in-Chief of the Journal of Stem Cell Research, and is a respected peer reviewer, ensuring academic rigor across multiple orthopaedic publications.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Dimitrios G. Tsoukas’s legacy is deeply embedded in medical innovation, education, and regenerative orthopaedics. As a fellow member of ICRS (2024) and an American Board of Regenerative Medicine Diplomat, he continues to push the boundaries of biological orthopaedic science. His ongoing leadership in global campaigns like “STOP Sports Injuries in Children” and collaborative research with biotechnology leaders like Terumo BCT, Arthrex, and Lipogems positions him as a visionary in the future of personalized, minimally invasive care. His legacy will endure through the institutions he built, the surgeons he trained, and the global initiatives he leads.

HONORS AND RECOGNITIONS

Dr. Tsoukas has received numerous accolades recognizing his contributions to orthopaedic science and Greek athletics. Among these are the Silver Award for Surgical Innovation at the Boussias Healthcare Business Awards 2021, the Med Professionals Honor for Stem Cell Innovation (2022), and several sports awards acknowledging his contributions to Greek basketball and volleyball. He holds the rare distinction of being enlisted in the Guinness World Records for medical contributions to the record-setting Athinaikos female basketball team.

OTHER SIGNIFICANT AFFILIATIONS AND LICENSES

Dr. Tsoukas maintains international medical licensure in Switzerland and Dubai, and continues to collaborate with organizations such as ECOSEP, CEV, and Smith & Nephew’s European Knee Advisory Board. These affiliations highlight his global reach and his role in shaping orthopaedic protocols across continents. His role as Head Doctor for National and Professional Teams underscores his credibility and trust within elite athletic circles.

NOTABLE PUBLICATIONS

"Prospective Observational Study of a Non-Arthroscopic Autologous Cartilage Micrografting Technology for Knee Osteoarthritis" 

  • Author: Dimitrios Tsoukas; Ilie Muntean; Christos Simos; Ruben Sabido-Vera
  • Journal: Bioengineering
  • Year: 2023